Literature DB >> 9576666

Terson syndrome: CT evaluation in 12 patients.

C E Swallow1, J S Tsuruda, K B Digre, M J Glaser, H C Davidson, H R Harnsberger.   

Abstract

PURPOSE: Terson syndrome may be overlooked in the acute setting and often requires ophthalmologic intervention to prevent long-term visual loss. In this syndrome, vitreous or retinal hemorrhage results from an abrupt rise in intracranial pressure, leading to retinal venous hypertension and intraocular hemorrhage. Our objective was to determine whether imaging findings could be discovered that might facilitate an earlier diagnosis.
METHODS: Our inpatient medical record data base for 1991-1996 listed 11 patients with Terson syndrome. The medical records of these 11 patients were reviewed retrospectively and compared with their noncontrast head CT scans and with scans of 10 control subjects. One additional case was discovered prospectively, for a total of 12 patients. Three radiologists unaware of the patients' history evaluated CT scans of the orbits for evidence of intraocular hemorrhage.
RESULTS: CT findings in eight patients were suggestive of retinal hemorrhage manifested by a retinal crescent or nodule that was slightly hyperdense relative to the vitreous humor. There was a high degree of concordance between the retrospective and independent reviews.
CONCLUSION: Retinal nodularity and crescentic hyperdensities are evident on CT scans in the majority of patients with Terson syndrome. Although findings are subtle and not present in all cases, in the setting of subarachnoid hemorrhage they suggest retinal hemorrhage and warrant detailed fundoscopic evaluation.

Entities:  

Mesh:

Year:  1998        PMID: 9576666      PMCID: PMC8337382     

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  13 in total

1.  Inconsistent detection of subhyaloid hemorrhage in the globe using computed tomography.

Authors:  Hisanao Akiyama
Journal:  Emerg Radiol       Date:  2012-02-17

2.  Magnetic resonance imaging findings of Terson's syndrome suggesting a possible vitreous hemorrhage mechanism.

Authors:  Masashi Sakamoto; Kimitoshi Nakamura; Maho Shibata; Kunio Yokoyama; Mitsuru Matsuki; Tsunehiko Ikeda
Journal:  Jpn J Ophthalmol       Date:  2010-04-18       Impact factor: 2.447

3.  Neurological picture. Terson's syndrome in subarachnoid haemorrhage.

Authors:  S J Resnick; A A Rabinstein
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-03       Impact factor: 10.154

4.  Terson syndrome in conjunction with ruptured intracranial aneurysm and penetrating intracranial injury: a review of two cases.

Authors:  Matt Rheinboldt; Kirenza Francis; David Parrish; Derrick Harper; John Blase
Journal:  Emerg Radiol       Date:  2013-10-31

5.  Computed Tomography Diagnosis of Terson Syndrome.

Authors:  Olga R Rosenvald; Sashank Prasad
Journal:  Neurohospitalist       Date:  2016-06-22

Review 6.  A systematic approach to CT evaluation of orbital trauma.

Authors:  Aaron M Betts; William T O'Brien; Brett W Davies; Omaya H Youssef
Journal:  Emerg Radiol       Date:  2014-04-23

7.  Terson syndrome in subarachnoid hemorrhage, intracerebral hemorrhage, and traumatic brain injury.

Authors:  Patrick Czorlich; Christos Skevas; Volker Knospe; Eik Vettorazzi; Gisbert Richard; Lars Wagenfeld; Manfred Westphal; Jan Regelsberger
Journal:  Neurosurg Rev       Date:  2014-08-31       Impact factor: 3.042

8.  A patient of terson's syndrome for ocular surgery: Perianesthetic concerns.

Authors:  Puneet Khanna; Dalim Kumar Baidya; Rakesh Garg; Dilip Shende
Journal:  Saudi J Anaesth       Date:  2013-01

9.  Terson syndrome caused by intraventricular hemorrhage associated with moyamoya disease.

Authors:  Ho Sang Kim; Sang Weon Lee; Soon Ki Sung; Eui Kyo Seo
Journal:  J Korean Neurosurg Soc       Date:  2012-06-30

Review 10.  An explanation for Terson syndrome at last: the glymphatic reflux theory.

Authors:  Ashwin Kumaria; Anna M Gruener; Graham R Dow; Stuart J Smith; Donald C Macarthur; Harshal A Ingale
Journal:  J Neurol       Date:  2021-06-25       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.